The program will draw upon recent clinical advances and guidelines, as well as the presenters’ clinical experience, to provide a practical approach to diagnosis and management of patients with interstitial lung disease (ILD).  The format will be primarily case-based discussions, with presentation of evidence where it helps inform management decisions. The participant will come away from the conference with increased confidence in diagnosing and managing patients with a variety of interstiti...

The list of course topics and subtopics was adapted from the ABPN’s description of the board and recertification examinations. The time allotted for each topic is based upon the approximate distribution of the subject matter as given by the ABPN. Our course will provide an excellent review of board exam and recertification topics primarily through case-based learning and help the learner identify areas that require further study. The learner can then review and prepare further in these areas pri...

Join us Tuesday, May 4, 2021, at 7AM EST for a virtual, live panel discussion, 1-hour CME featuring experts and leadership across the Thyroid Cancer Program.High-risk thyroid cancer remains a therapeutic challenge. This live, case-based panel discussion will cover the basics of high risk thyroid cancer from presentation and diagnosis to treatment. A comprehensive discussion on standard and advanced therapeutics will be included. The necessity of a multidisciplinary advanced care team for the man...

Join us Monday, April 19, 2021, at 7AM ET for a virtual, live panel discussion, 1-hour CME featuring experts and leadership across the Sarcoma Program.Moderated by Kristy L. Weber, MD, this panel will include specialists from orthopaedic oncology, medical oncology, surgical oncology, and radiation oncology from Penn Medicine’s Abramson Cancer Center.Sarcoma remains a complex condition that requires a coordinated care approach. This live panel discussion will cover the basics of sarcoma from pres...

This course is designed to provide the audience with the most current clinical advances in ophthalmology and highlight on-going research at the Scheie Eye Institute in the fields of glaucoma, anterior segment, retinal diseases, genetics, oculoplastic surgery, neuro-ophthalmology and ocular pathology.

The link to join this conference virtually has been emailed to all preregistered attendees. Please be sure to check your junk/spam mailbox for our email.*Contact us immediately if you have not received it.* While the incidence of heart failure with reduced ejection fraction (HFrEF) has decreased, the incidence of heart failure with preserved ejection fraction (HFpEF) continues to rise, accounting for ~50% of heart failure hospitalizations. Patients with HFpEF are markedly limited in terms o...